Health Care Policy

Pharmaceutical & Drug Policy Comments on Medicare Drug Price Negotiation Program’s Section 30.2 and Part B high spend drugs

Samuel R. Bagenstos, Richard G. Frank, Kristi Martin, Rachel Sachs, Christen Linke Young

July 14, 2025

Pharmaceutical & Drug Policy International reference pricing for prescription drugs

Christen Linke Young, Richard G. Frank, Rachel Sachs

July 9, 2025

Health Insurance The changing landscape of primary care: An analysis of payer-primary care integration

Loren Adler, Samantha Crow, Matthew Fiedler, Richard G. Frank, Rahul Fernandez, Derek Lake, Robert Tyler Braun

July 7, 2025

Pharmaceutical & Drug Policy Comments on Medicare Drug Price Negotiation Program

Richard G. Frank, Rachel Sachs, Christen Linke Young

July 2, 2025

Experts

Derek Cummings Nonresident Fellow - Economic Studies, Center on Social Dynamics and Policy

Paul B. Ginsburg Nonresident Senior Fellow - Economic Studies, Center on Health Policy

Niam Yaraghi Nonresident Senior Fellow - Governance Studies, Center for Technology Innovation (CTI)

Matthew Fiedler Joseph A. Pechman Senior Fellow - Economic Studies, Center on Health Policy

Steven M. Lieberman Nonresident Fellow - Economic Studies, Center on Health Policy

Marta E. Wosińska Senior Fellow - Economic Studies, Center on Health Policy

results at a time